[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,514,832
  • Shares Outstanding, K 284,742
  • Annual Sales, $ 21,840 M
  • Annual Income, $ 1,678 M
  • EBIT $ 2,675 M
  • EBITDA $ 5,137 M
  • 60-Month Beta 0.22
  • Price/Sales 1.94
  • Price/Cash Flow 6.46
  • Price/Book 1.68

Options Overview Details

View History
  • Implied Volatility 34.58% (-0.95%)
  • Historical Volatility 19.66%
  • IV Percentile 93%
  • IV Rank 79.43%
  • IV High 38.88% on 02/06/26
  • IV Low 17.97% on 08/15/25
  • Expected Move (DTE 12) 8.87 (5.94%)
  • Put/Call Vol Ratio 1.36
  • Today's Volume 165
  • Volume Avg (30-Day) 316
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 12,774
  • Open Int (30-Day) 11,784
  • Expected Range 140.44 to 158.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $2.77
  • Number of Estimates 7
  • High Estimate $2.78
  • Low Estimate $2.75
  • Prior Year $3.35
  • Growth Rate Est. (year over year) -17.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
144.51 +3.32%
on 04/29/26
159.95 -6.65%
on 04/17/26
-7.03 (-4.50%)
since 04/01/26
3-Month
144.51 +3.32%
on 04/29/26
187.35 -20.30%
on 02/24/26
-10.66 (-6.66%)
since 01/30/26
52-Week
127.59 +17.03%
on 11/06/25
187.35 -20.30%
on 02/24/26
+16.02 (+12.02%)
since 05/01/25

Most Recent Stories

More News
BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition

Business Group on Health, Cigna Healthcare, and the American Heart Association highlight BD's comprehensive and innovative approach to advancing employee health and well being

BDX : 149.31 (+0.18%)
BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology

With the launch of CentroVena One™, BD brings a first ‑ of ‑ its ‑ kind insertion system to market that simplifies central line placement for clinicians and enhances care in acute...

BDX : 149.31 (+0.18%)
BD Board Declares Dividend

FRANKLIN LAKES, N.J. , April 28, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has...

BDX : 149.31 (+0.18%)
BD to Present at Bank of America Securities Health Care Conference

FRANKLIN LAKES, N.J. , April 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank...

BDX : 149.31 (+0.18%)
What You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release

Becton, Dickinson and Company is set to report its fiscal second-quarter earnings next month, and analysts project a double-digit earnings decline.

XLV : 145.16 (-0.57%)
$SPX : 7,230.12 (+0.29%)
BDX : 149.31 (+0.18%)
BD Earns Industry Top Honors for Transparency, Resiliency and Partnership

FRANKLIN LAKES, N.J. , April 16, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been recognized by the Healthcare Industry...

BDX : 149.31 (+0.18%)
BD to Announce Financial Results for its Second Quarter of Fiscal 2026

FRANKLIN LAKES, N.J. , April 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an...

BDX : 149.31 (+0.18%)
For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

New study findings published in the Journal of Clinical Medicine highlight the ease of use and comfort of BD PureWick® Female External Catheter can support a better night's rest

BDX : 149.31 (+0.18%)
BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union

CE Marking and ARCH clinical trial data position the Livertyâ„¢ TIPS Stent Graft to expand treatment options for patients with advanced liver disease

BDX : 149.31 (+0.18%)
3 Dividend Kings With 50+ Years of Raises Are Trading at a Huge Discount. Analysts Say Buy Before They Rebound

Three Dividend Kings, Sysco, P&G, and BD, look oversold or near it, offering yield, resilience, and possible upside in a volatile market.

SYY : 74.05 (-0.88%)
PG : 147.26 (+0.12%)
BDX : 149.31 (+0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 153.60
2nd Resistance Point 151.90
1st Resistance Point 150.60
Last Price 149.31
1st Support Level 147.60
2nd Support Level 145.90
3rd Support Level 144.60

See More

52-Week High 187.35
Fibonacci 61.8% 164.52
Fibonacci 50% 157.47
Fibonacci 38.2% 150.42
Last Price 149.31
52-Week Low 127.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.